Table 2.
Vit. D ≥ 30 ng/mL Group 1 | 30 > Vit. D ≥ 20 ng/mL (insufficiency) Group 2 | 20 > Vit. D ≥ 10 ng/mL (moderate deficiency) Group 3 | Vit. D < 10 ng/mL (severe deficiency) Group 4 | |
---|---|---|---|---|
Patients (n, %) | 8 (19) | 11 (26) | 13 (31) | 10 (24) |
Sex (M/F) | 3/5 | 7/4 | 12/1 | 8/2 |
Age (years, mean, SD) | 64 ± 18 | 64 ± 13 | 60 ± 6.9 | 74 ± 11 |
BMI (mean, SD) | 27 ± 4 | 28 ± 4.10 | 31 ± 6.02 | 29 ± 4.75 |
SOFA score (mean, SD) | 2 ± 0.74 | 3 ± 1.81 | 2 ± 1.51 | 3 ± 1.06 |
Smoking habit | ||||
Smokers | 0 | 0 | 2 | 0 |
Ex-smokers | 3 | 4 | 5 | 6 |
Never smokers | 5 | 7 | 6 | 4 |
Patients with comorbidity | 6 | 11 | 9 | 10 |
Patients without comorbidity | 2 | 0 | 4 | 0 |
Comorbidity | ||||
Hypertension | 5 | 8 | 5 | 8 |
Cardiovascular disease | 2 | 6 | 4 | 4 |
Chronic kidney disease | 2 | 6 | 4 | 4 |
Diabetes type II | 2 | 4 | 3 | 2 |
Cerebrovascular disease | 0 | 4 | 0 | 1 |
Psycosis, depression, anxiety | 1 | 4 | 2 | 3 |
Malignancy | 1 | 1 | 2 | 1 |
COPD | 1 | 2 | 0 | 2 |
Asthma | 2 | 0 | 0 | 0 |
BMI body mass index, SOFA sequential organ failure assessment, COPD chronic obstructive pulmonary disease, Vit vitamin